The Medicare data contradict results from the TCW randomized trial but better represent real-world practice, say authors.
With growth in percutaneous fixes for the valve, surgeons at STS 2025 called for innovation, team-based care, and more data.
Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a ...
BACKGROUND: The optimal coronary stenting technique for true left main bifurcation lesions is uncertain. EBC MAIN (European ...
Sunderland NHS specialists showed off advanced heart procedures live to a global audience last week by live-streaming ...
The following is a summary of “Comparative Outcomes of Left Main and Non-Left Main Percutaneous Coronary Intervention from ...
Cagent Vascular, Inc. announced the launch of its Serranator SL-Pro percutaneous transluminal angioplasty (PTA) serration ballo ...
Cagent Vascular, Inc., a developer of serration technology for vessel dilation in endovascular interventions, announced the sta ...
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, toda ...
Members of the team spoke with the News about their experiences performing the BATMAN procedure and its future implications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback